Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma.

The Journal of urology - 1 Mar 2000

Wu T T, Chen J H, Lee Y H, Huang J K

Abstract excerpt

PURPOSE: We assess the prognostic significance of bcl-2 expression, p53 mutation and ki-67 index for low grade, superficial transitional cell bladder carcinoma. MATERIALS AND METHODS: The medical records of 93 cases of primary, low grade (24 G1, 69 G2), superficial (70 pTa, 23 pT1) transitional c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Transitional Cell
Share to Genes, bcl-2
Share to Genes, p53

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ki-67 Antigen

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Prognosis

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 10687971
DOI: 10.1016/s0022-5347(05)67798-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-10687971-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma.PMID 10687971Read ↗

p53 mutation and bcl-2 expression in transitional cell carcinoma of the urinary bladder.Semantic proximity Read ↗

bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection.Semantic proximity Read ↗

The predictive value of p53, p27(kip1), and alpha-catenin for progression in superficial bladder carcinoma.Semantic proximity Read ↗

Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.Semantic proximity Read ↗

Cyclin D1 expression in papillary superficial bladder cancer: Its association with other cell cycle‐associated proteins, cell proliferation and clinical outcomeSemantic proximity Read ↗

STAGE PROGRESSION IN TA PAPILLARY UROTHELIAL TUMORS: RELATIONSHIP TO GRADE, IMMUNOHISTOCHEMICAL EXPRESSION OF TUMOR MARKERS, MITOTIC FREQUENCY AND DNA PLOIDYSemantic proximity Read ↗

Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.Semantic proximity Read ↗

Correlation of allelic loss of the P53 gene and tumor grade, stage, and malignant progression in bladder cancer.Semantic proximity Read ↗

The relation of mutant p53 accumulation in transitional cell carcinoma of bladder with pathological stage, grade, recurrence and survival.Semantic proximity Read ↗

p53 gene mutation in recurrent superficial bladder cancer.Semantic proximity Read ↗

bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancerSemantic proximity Read ↗

Clinical value of PTEN in patients with superficial bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.